An international evidence review has found that certain nutritional supplements can increase the effectiveness of antidepressants for people with clinical depression.
Bevespi Aerosphere is the first product approved using AstraZeneca’s Co-Suspension Technology.
Study in flies could have major implications for human disease.
While not binding, the panel's view carries weight in FDA's final decision whether to approve a drug.
Scientists have solved a decades-old medical mystery by finally identifying a previously unknown molecule which is attacked by the immune system in people with Type 1 diabetes.
The current test is only able to analyze part of the human immune system, namely the B-cells but not the T-cells.
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses.
Canadian pharmaceutical company Valeant named Joseph Papa as its new chief executive and chairman on Monday.
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Heroin and opioid painkiller abuse is a growing, deadly problem that has become a top political issue in many states.
Photodynamic therapy (PDT) in medicine usually uses a substance that reacts to light and converts the oxygen in the tissue into aggressive radicals.
The findings could enhance vaccines and make them much more effective.
The treatment was originally intended to demonstrate the safety of the latest generation of the therapies.
Harvard Medical School scientists have found a compound that in laboratory dishes blocks the dengue virus in two ways.